Author:
Hirayama Kazuhide,Masui Kimihiko,Hamada Akihiro,Shichiri Yasumasa,Masuzawa Naoko,Hamada Shinshichi
Reference23 articles.
1. Long-term risk of re-treatment of patients using α-blockers for lower urinary tract symptoms;De la Rosette;J Urol,2002
2. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia;Roehrborn;Urology,2002
3. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study;Roehrborn;Eur Urol,2010
4. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study;Roehrborn;J Urol,2008
5. Efficacy and safety of dutasteride in Japanese men with benign prostatic hyperplasia;Tsukamoto;Int J Urol,2009
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献